Ranbaxy

Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

First Post

India's Largest Pharmacy Chain Halts Sales Of Ranbaxy Drugs

India's Largest Pharmacy Chain Halts Sales Of Ranbaxy Drugs

Pharmalot

Indian Hospital Bans Ranbaxy Drugs As Docs Question Safety

Indian Hospital Bans Ranbaxy Drugs As Docs Question Safety

Pharmalot

Ranbaxy said to be eyeing major cuts to sales force, mainly in U.S.

Ranbaxy said to be eyeing major cuts to sales force, mainly in U.S.

Fierce Pharma

Will Ranbaxy Labs Be Excluded From Medicare And Medicaid?

Will Ranbaxy Labs Be Excluded From Medicare And Medicaid?

Forbes

The Ranbaxy Whistleblower And The Scheme To Fool The FDA

The Ranbaxy Whistleblower And The Scheme To Fool The FDA

Pharmalot

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Forbes

India's Ranbaxy surprises with Q4 loss, sees modest sales growth in 2013

India's Ranbaxy surprises with Q4 loss, sees modest sales growth in 2013

Reuters

Ranbaxy Slams Consumers For Seeking Lipitor Recall

Ranbaxy Slams Consumers For Seeking Lipitor Recall

Pharmalot

American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor

American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor

Economic Times, India